MediPharm Labs 29/08/2019

View from the C-Suite: Patrick McCutcheon, Chief Executive Officer, MediPharm Labs Corp., tells his company’s story

The View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment.

See the latest View from the C-Suite videos here.

About MediPharm Labs Corp. (TSX: LABS)

Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-like cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices designed facility and ISO standard built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines having 300,000 kg of annual processing capacity to deliver pure, safe and precisely-dosed cannabis products for its customers. Through its wholesale, white label and tolling platforms, they formulate, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, the Company also completed its first commercial export to Australia in June 2019 and is nearing completion of its Australian extraction facility expected in 2019 with 75,000 kg of annual processing capacity.

About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income.Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijingand Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited

Back to News

Related Articles

MediPharm Labs

MediPharm Labs Reports Q4 2018

07/05/2019 Read more
MediPharm Labs

MediPharm Labs Reports Q1 2019

13/05/2019 Read more
MediPharm Labs

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence

23/05/2019 Read more
MediPharm Labs

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

25/06/2019 Read more